You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The South San Francisco, California cellular analysis firm alleges IonPath has infringed two patents and has been intereferening in its contracts.
The team used this system to perform orthogonal and multiplexed genome engineering of endogenous targets using up to 25 individual CRISPR RNAs.
Cytena has developed a printer technology that allows single cell isolation for genomics research and clonal cell line development for biopharmaceutical production.
The researchers used what they called a "systems NMR" approach to simultaneously measure RNA, proteins, and metabolites as well as their interactions.
Mass cytometry revenues increased 28 percent to $17.5 million year over year, but microfluidics revenues dropped 16 percent to $10.7 million.
QGel is looking to raise $60 million to begin clinical testing of its technology for pharmaceutical product development for targeted cancer therapy.
The assets include intellectual property relevant to iPSC-based phenotypic drug discovery and an existing product business around iPSC-derived cells.
The work is being conducted as part of the Human Cell Atlas initiative, which was launched in 2016 to create a reference atlas of all human cell types.
The new partnership will support the analysis of glycans in 30,000 human samples by the end of 2021.
APEX-seq builds on a proteomic labelling technique and offers a new spatial genomics tool for looking at the life of transcripts within the cell.
So-called DNA microscopy is the latest entrant to the rapidly growing spatial genomics field that combines molecular analysis with imaging.
The company is seeing increasing interest in its GeoMx platform with numerous studies from early users presented last month at AACR.
The assay examine phenotypic behaviors of isolated cancer cells from biopsies at initial diagnosis.
NanoCellect's Wolf Cell Sorter and N1 single-cell plate dispenser uses lasers and piezoelectricity to gently sort cells for downstream applications.
Kiyatec's cell-based assays model and predict patient therapeutic response to drive cancer drug development and potentially guide treatment.
Year-over-year revenues increased on strong demand for the company's Helios and Hyperion imaging mass cytometry systems.
Canopy aims to use Zellkraftwerk's microfluidic cell-capture technology to further develop drug-development research and biomarker discovery.
The effort, outlined in a Development Cell paper published online today, aims to complement the ongoing Human Cell Atlas initiative, but with a focus on pediatric health.
The firm will use the funding to expand its sales activities, as well as further develop and explore potential applications for its single-cell printer lab technology.
Researchers defined six malignant cell clusters with single-cell transcriptomes and genotypes for thousands of acute myeloid leukemia cells.
The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.
Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.
A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.
In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.